Abbott Executive and Leadership Team

Harlene Spinda, the Chief Financial Officer at Abbott, directs financial strategy and operations. Overseeing all fiscal activities, Spinda ensures robust financial planning and analysis to support Abbott's global healthcare initiatives. This leadership position involves managing budgets, forecasting revenue, and optimizing resource allocation across diverse business segments, including medical technologies, diagnostics, nutrition, and branded generic medicines. Spinda's oversight extends to financial reporting and compliance, ensuring adherence to regulatory standards and driving shareholder value. The Chief Financial Officer's role is critical in maintaining Abbott's financial health and enabling its mission to improve health outcomes worldwide. By providing strategic financial guidance, Harlene Spinda supports the company's commitment to innovation and its expansion into new markets, solidifying Abbott's position as a leader in global healthcare solutions.

Saeed Khan, the Regional Chief Financial Officer, Middle, Africa, & Cis (East, Turkey, Pakistan) at Abbott, directs financial operations and strategic planning for a significant global territory. Khan oversees financial performance, budgeting, and forecasting across diverse markets, ensuring fiscal discipline and driving profitable growth. This role involves managing financial risks and opportunities specific to the Middle East, Africa, and CIS regions, adapting Abbott's financial strategies to local economic conditions and regulatory landscapes. The Regional Chief Financial Officer's responsibilities include fostering strong relationships with regional stakeholders and ensuring alignment with Abbott's global financial objectives. Saeed Khan's leadership is instrumental in supporting Abbott's mission to improve health outcomes by enabling effective resource deployment and financial stewardship in these key growth areas. Khan's expertise ensures financial stability and supports expansion initiatives across the designated territories.

Maithilee Mistry, the Group Chief Financial Officer (India) at Abbott, leads financial strategy and operations within the vital Indian market. Mistry manages all aspects of financial planning, analysis, and reporting, ensuring robust fiscal management for Abbott's diverse business units in India. This position requires deep understanding of the Indian economic landscape and regulatory environment to optimize financial performance and drive sustainable growth. The Group Chief Financial Officer's responsibilities include overseeing budgeting, cash flow management, and investment strategies to support Abbott's expansion and product development initiatives in the region. Maithilee Mistry's financial acumen is crucial for navigating market complexities and maximizing Abbott's impact in India, aligning with the company's global mission to improve health and well-being. Mistry's leadership ensures financial integrity and supports strategic decision-making for Abbott's operations in India.

Deusdedet Junior, the Chief Financial Officer & Director, Finance at Abbott, manages critical financial functions and strategic fiscal planning. Junior oversees financial operations, ensuring accuracy in reporting and compliance with all relevant regulations. This role involves developing financial models, managing budgets, and providing insights to support executive decision-making across Abbott's global healthcare portfolio. The Chief Financial Officer's responsibilities extend to optimizing financial performance, identifying cost-saving opportunities, and driving revenue growth initiatives. Deusdedet Junior's financial leadership is essential for maintaining Abbott's financial stability and supporting its mission to improve health outcomes by enabling strategic resource allocation and sound fiscal management. Junior's dedication ensures financial integrity and supports Abbott's growth objectives.

Philip Boudreau, the Executive Vice President, Finance and Chief Financial Officer at Abbott, directs the company's comprehensive financial strategy and operations. Boudreau oversees all aspects of financial planning, analysis, reporting, and treasury functions, ensuring fiscal discipline and driving sustainable growth across Abbott's global healthcare businesses. This senior leadership role involves managing capital allocation, investor relations, and risk management to support Abbott's mission of improving health outcomes worldwide. The Executive Vice President, Finance and Chief Financial Officer's responsibilities include providing strategic financial guidance to the executive team and the Board of Directors, ensuring alignment with long-term corporate objectives. Philip Boudreau's extensive financial expertise is critical for navigating complex market dynamics, optimizing financial performance, and enabling Abbott's continued innovation and expansion in medical technologies, diagnostics, nutrition, and branded generic medicines.

Sonia Ychocan, the Director, Finance & Chief Financial Officer at Abbott, manages key financial operations and strategic fiscal initiatives. Ychocan oversees financial reporting, budgeting, and forecasting, ensuring accuracy and compliance across designated areas of responsibility. This role involves providing critical financial analysis to support business decisions and drive operational efficiency. The Director, Finance & Chief Financial Officer's responsibilities include managing financial resources effectively and contributing to the overall financial health of the organization. Sonia Ychocan's financial leadership supports Abbott's commitment to innovation and its mission of helping people live healthier lives by ensuring sound financial practices and strategic resource deployment. Ychocan's work reinforces Abbott's financial integrity and operational effectiveness.

James Cocchella, the Chief Technology Officer at Abbott, architects the company's technological vision and execution. Cocchella drives innovation across Abbott's diverse product lines, from advanced medical devices to cutting-edge diagnostics and nutritional products. This role involves identifying emerging technologies and integrating them into Abbott's research and development pipeline, ensuring the company remains at the forefront of healthcare innovation. The Chief Technology Officer's responsibilities include fostering a culture of technological advancement and overseeing the development of scalable, secure, and efficient technological solutions that address critical medical needs. James Cocchella's leadership ensures that Abbott leverages technology to enhance product performance, improve patient outcomes, and expand market reach globally. By championing technological progress, Cocchella directly contributes to Abbott's mission of helping people live healthier lives through science and innovation.

Corey Adams, the Cybersecurity & Compliance Chief of Staff at Abbott, spearheads the integration of robust security protocols and regulatory adherence across the organization. Adams ensures that all technological and operational frameworks meet stringent global compliance standards, safeguarding sensitive data and intellectual property. This critical function involves developing and implementing comprehensive cybersecurity strategies to protect Abbott's digital infrastructure from evolving threats. The Chief of Staff's role extends to coordinating compliance efforts across various departments, ensuring alignment with industry regulations and company policies. Corey Adams's strategic oversight is vital for maintaining trust with patients, partners, and stakeholders, reinforcing Abbott's commitment to ethical operations and data integrity. By managing these complex areas, Adams directly supports Abbott's mission to deliver innovative healthcare solutions securely and responsibly.

Christopher Piorkowski, the Chief Marketing Officer (Ep) & Divisional Vice President, Medical Affairs, Abbott Ep at Abbott, drives market strategy and medical affairs for Abbott's Electrophysiology division. Piorkowski leads the development and execution of comprehensive marketing plans, enhancing brand visibility and market penetration for innovative cardiac rhythm management solutions. This dual role involves overseeing medical affairs, ensuring scientific integrity and clinical support for Abbott's EP products. The Chief Marketing Officer's responsibilities include identifying market opportunities, shaping product positioning, and fostering strong relationships with healthcare professionals and key opinion leaders. Christopher Piorkowski's strategic direction is essential for advancing Abbott's leadership in cardiac care and improving patient lives through cutting-edge technology and effective market engagement. Piorkowski's leadership ensures alignment between commercial objectives and medical excellence.

Thomas Northenscold, the Vice President, Information Technology & Chief Information Officer at Abbott, directs the company's global IT infrastructure and strategy. Northenscold oversees the implementation and management of technology solutions that support Abbott's diverse operations, from research and development to manufacturing and commercialization. This leadership role involves ensuring the security, reliability, and scalability of IT systems, enabling seamless business processes and data management across all divisions. The Chief Information Officer's responsibilities include driving digital transformation initiatives, fostering innovation in IT, and aligning technology investments with Abbott's strategic goals. Thomas Northenscold's expertise is critical in leveraging technology to enhance operational efficiency, support product development, and maintain Abbott's competitive edge in the global healthcare market. Northenscold's vision guides Abbott's technological advancement.